The 5 key players our Non-Opioid Pain Drugs report profiles, and other companies free public records show in this market.
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Vertex Pharmaceuticals | — | 264 reports |
| 2 | Pacira BioSciences | — | 66 reports |
| 3 | Heron Therapeutics | — | 66 reports |
| 4 | Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 5 | Grunenthal | — | 66 reports |
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| LGM Pharma | |
| Stevens J | |
Hikma Pharmaceuticals PLC |
|
| Actavis Laboratories Ut Inc |
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
One report for each place. Each tile opens that place's report.
Compare all 33 places for Non-Opioid Pain Drugs, with active trials
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.